PuraMatrix® has demonstrated efficacy in multiple models for hemostasis (CE Mark approved, trade name PuraStat®), tissue regeneration, acute myocardial infarction, therapeutic protein and stem cell delivery, and CNS injury. PuraMatrix® can re-hydrate and provide mechanical support for disc height collapse in degenerated IVDs, anti-adhesion, polyp resection, and bone formation. PuraMatrix® has also been used to repair and restore visual function in the CNS after damage.
The ability of PuraMatrix® to be injected through fine gauge needles and catheters is ideal for minimally invasive surgery. Application of PuraMatrix® through small incisions to internal body tissues facilitates tissue regeneration, hemostasis, (CE Mark approved, trade name PuraStat®) and drug delivery to the affected area while reducing the risks associated with open surgeries.
Click here for peer-reviewed publications of PuraMatrix® in clinical applications.